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Edited by Hans EklundAbstract The aminopeptidase from Streptomyces griseus
(SGAP) has been cloned and expressed in Escherichia coli. By
growing the cells in the presence of 1 M sorbitol at 18 C, the
protein was obtained in a soluble and active form. The amino
acid sequence of the recombinant SGAP contained four amino
acids diﬀering from the previously published sequence. Re-
sequencing of the native protein indicated that asparagines 70
and 184 are in fact aspartic acids as in the recombinant protein.
Based on the crystal structure of SGAP, Glu131 and Tyr246
were proposed to be the catalytic residues. Replacements of
Glu131 resulted in loss of activity of 4–5 orders of magnitude,
consistent with Glu131 acting as the general base residue.
Mutations in Tyr246 resulted in about 100-fold reduction of
activity, suggesting that this residue is involved in the stabiliza-
tion of the transition state intermediate.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Aminopeptidases (APs) are a group of exopeptidases that
catalyze the cleavage of amino acids from the amino-terminus
of proteins and peptides. APs activity is associated with many
biological functions such as protein maturation, protein deg-
radation, hormone level regulation and cell-cycle control.
Therefore, these enzymes play an important role in many
pathological conditions including cancer, cataract, cystic ﬁ-
brosis, leukemia and HIV infection [1–6].
APs can be classiﬁed into families and clans based on their
sequence homology. Many known clan M APs are metallo-
peptidases [7,8] and family M28 APs includes bacterial and
human enzymes that accommodate two Zn ions in their active
site. Some of the bacterial APs in this family are Streptomyces
griseus aminopetidase (SGAP), Aeromonas proteolytica ami-* Corresponding author. Fax: +972-4-8293399.
E-mail address: yshoham@tx.technion.ac.il (Y. Shoham).
Abbreviations: Leu-pNA, Leucine-para-nitroanilide; SGAP, Strepto-
myces griseus aminopeptidase
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doi:10.1016/j.febslet.2004.07.001nopeptidase (AAP) and the putative aminopeptidase from
Bacillus subtilis (BSAP). Family M28 includes also human
proteins such as the prostate speciﬁc membrane antigen
(PSMA) and the glutamate carboxypeptidase II (GCP-II)
[9,10]. The catalytic domains of these two medically important
human proteins share 30% identity with bacterial APs, in-
cluding the conserved catalytic residues and the Zn binding
ligands [11–13].
To date, very few double-Zn APs have been characterized
and limited mechanistic data are available on this class of
metalloaminopeptidases. Revealing the mechanism of co-cat-
alytic active site APs is particularly important in light of the
potential for designing new inhibitors acting as pharmaceuti-
cals [14,15]. Bacterial APs are also excellent candidates for
structure–function analysis, since they can be easily produced
and puriﬁed as recombinant proteins.
SGAP is a 30 kDa, thermostable, double-zinc AP that pre-
fers large hydrophobic amino-terminus residues in its sub-
strates [16,17]. We have recently solved the crystal structure of
SGAP together with its reaction products [11–13]. Based on
the crystallographic results and molecular dynamics simula-
tions, a catalytic mechanism involving Glu131 and Tyr246 was
proposed [12] (Fig. 1). Glu131 is suggested to act as a general
base activating a water molecule for a nucleophilic attack on
the substrate carbonyl carbon, and as a proton ‘‘shuttle’’
during the catalytic cycle, as was ﬁrst proposed for thermolysin
[18]. Tyr246 possibly polarizes the carbonyl carbon of the N-
terminal substrate [12] (Fig. 1).
In this study, we describe the cloning and site directed mu-
tagenesis of the sgap gene from S. griseus. The resulting cat-
alytic mutants were puriﬁed and their catalytic properties were
determined, providing for the ﬁrst time biochemical conﬁr-
mation to their catalytic role.2. Materials and methods
2.1. Cloning of the sgap gene
Based on the published amino acid sequence of SGAP [19], several
degenerative primers were designed for ampliﬁcation of the gene via
PCR using S. griseus (DSM 40855) chromosomal DNA as a template.
The best results were obtained with a C-terminal primer that included
the last 22 amino acids of the gene. Both primers were designed in a
way that enabled the cloning of the gene into the T7 polymerase ex-
pression vector pET9d (Novagen). The N-terminal primer (50-blished by Elsevier B.V. All rights reserved.
Fig. 1. The proposed catalytic pathway of SGAP. An acidic residue (Glu131) activates a zinc-bound water molecule and an additional residue
(Tyr246) polarizes the carbonyl carbon and stabilizes the transition state. Dashed lines indicate stabilizing interactions and/or hydrogen bonds in the
catalytic pathway; (Pep) – the incoming peptide/protein substrate.
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the ATG translated start codon inside the NcoI (CCATGG) restriction
site. The C-terminal primer (50-GCGGATCCTTAGGTTGGTGG-
GTTCGCCGGTGCCGCTGCTCAGGGTCCAAATGGCATGTG-
CTGCTGCATCGCTGTTGCGGTCGAGGGCGGTGTCGTTGA-
TG-30) included BamHI site (GGATCC) at the end of the gene. Fol-
lowing PCR, the ampliﬁed product was digested with NcoI and
BamHI, cloned into pET9d, and the SGAP gene was sequenced. The
protein sequences of the recombinant and the native enzyme (puriﬁed
from pronase) were also veriﬁed using electrospray ionization ion trap
mass spectrometry (The Smoler Proteomic Center, Technion).
2.2. Expression and puriﬁcation of SGAP
E. coli BL21(DE3) (pET9d-SGAP) cells were grown in Luria Broth
(LB) containing kanamycin (25 lg/ml) for a few hours, at 37 C, and
then transferred to Terriﬁc Broth (TB) [20] supplemented with sorbitol
(1 M), betain (2.5 mM), phosphate buﬀer, pH 7 (50 mM), and kana-
mycin (25 lg/ml), (500 ml in 2-l shake ﬂasks, shaken at 180 rpm, 37
C). At a culture density of 0.6 OD600, the growth temperature was
reduced to 18 C and isopropyl b-D-thiogalactopyranoside (IPTG) was
added to a ﬁnal concentration of 100 lM.
Following 40 h of growth (ﬁnal OD600 of 12–15), cells from 1-l
culture were harvested (7000 rpm for 10 min), washed twice with 30
mM Tris–HCl, pH 8, and 1 mM CaCl2, and then resuspended in 45 ml
of 25 mM Tris–HCl, 3 mM NaCl, 1 mM CaCl2, and 0.05 mM ZnCl2,
pH 9. The cells were disrupted by two passages through a French
press (Spectronic instruments, Inc., Rochester, NY, USA) at room
temperature. The cell extract was centrifuged (13 000 rpm for 20 min at
4 C), and the soluble fraction was heat-treated (50 C, 20 min) and
centrifuged again. The soluble fraction containing the recombinant
SGAP was diluted 10-fold with water to decrease the ionic strength
and the pH was adjusted to 9.0. The sample was then loaded on a
HiPrepTM Q Sepharose (functional group –Nþ(CH3)3) Fast Flow
column XK 50/20 running at 40 ml/min with 3 mM NaCl, 25 mM
Tris–HCl, 1 mM CaCl2, and 0.05 mM ZnCl2, pH 9, and eluted with 7
mM NaCl in the same buﬀer (AKTA explorer (Pharmacia)). The en-zyme appeared as a distinct protein peak, which was collected and used
for biochemical characterization and crystallization experiments.
Protein concentrations were determined by the Bradford method, with
bovine serum albumin as a standard [21].
2.3. Site-directed mutagenesis
Site-directed mutagenesis was performed using the QuickChange
Site-directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA). The
mutagenic primers for all the mutants were as follows (Mutated nu-
cleotides are shown in bold):
E131A: 50-CCTGGTGGGGCGCCGCGGAGCTGGG-30 and 50-
CCCAGCTCCGCGGCGCCCCACCAGG-30; E131Q: 50-CTGGTG-
GGGCGCGGCAGGAGCTGGGCC-30 and 50-GGCCCAGCTCCT-
GCGCGCCCCACCAG-30; E131D: 50-GGTGGGGCGCGGATGA-
GCTCGGCCTGATC-30 and 50-GATCAGGCCGAGCTCATCCGC-
GCCCCACC-30; Y246A: 50-GCCTTCGACCGGTGCGCCCACTC-
CTCGTGC-30 and 50-GCACGAGGAGTGGGCGCACCGGTCGA-
AGGC-30; Y246F: 50-GCCTTCGACCGGTGCTTCCACTCCTCG-
TGCG-30 and 50-CGCACGAGGAGTGGAAGCACCGGTCGAAG-
GC-30; Y246S: 50-GCCTTCGACCGGTGCTCCCACTCCTCGTG-
CG-30 and 50-CGCACGAGGAGTGGGAGCACCGGTCGAAG-
GC-30. Y140F: 50-GGCTCGAAGTTCTACGTTAACAACCTGCC-
GTCCG-30 and 50-CGGACGGCAGGTTGTTAACGTAGAACTTC-
GAGCC-30.
All of the mutated genes were sequenced to conﬁrm that only the
desired mutations were inserted. The mutated proteins were overex-
pressed and puriﬁed as the wild type protein.
2.4. Kinetic studies
Kinetic studies were carried out by a continuous assay using L-leu-
cine-para-nitroanilide (leu-pNA) (Sigma) as a substrate. The continu-
ous reactions were performed at 30 C in a 1-ml cuvette. The assay
solution contained 650 ll of 50 mM MOPS, pH 8, 1 mM CaCl2, 0.05
mM ZnCl2 and 1 mg/ml BSA together with an appropriate diluted
enzyme and substrate concentrations ranging from 0.1 to 10 Km. The
increase in absorbance at 405 nm was followed continuously using an
194 Y. Fundoiano-Hershcovitz et al. / FEBS Letters 571 (2004) 192–196Ultrospec 2100 spectrophotometer (Pharmacia). The extinction coef-
ﬁcient at 405 nm used for para-nitroanilide was D ¼ 9:65 mM1 cm1
at pH 8. The catalytic constants, Km and kcat, were determined by non-
linear regression analysis with GraFit 5.0 [21].Fig. 2. Puriﬁcation of SGAP. ChromatogramofHiPrepTM QSepharose
Fast Flow anion exchange. OD 280 nm (solid line) and activity (closed
circles) (both in relative units), conductivity (dashed line) in ms cm1.3. Results and discussion
3.1. Cloning and sequence analysis of SGAP
The SGAP gene from S. griseus was cloned into pET9d via
PCR using degenerative primers [19] and was overexpressed in
E. coli cells. The sequence of the gene indicated that the re-
combinant SGAP is identical to the native protein puriﬁed
from pronase [19], except for four amino acids. The re-
combinant SGAP contained Tyr140, Arg240, Asp70 and
Asp184, instead of Phe140, Gln240, Asn70 and Asn184 that
appear in the native protein. To verify again the amino acid
sequence of the native protein (puriﬁed from pronase), it was
subjected to electrospray ionization ion-trap mass spectrome-
try (EIMS). The EIMS results indicated that the native protein
contains in fact aspartic acids in positions 70 and 184, and not
Asn as was published before. Thus, the recombinant SGAP
(rSGAP) obtained from S. griseus (DSM 40855) diﬀers only in
two amino acids (Phe140 and Gln240) from the native SGAP
obtained from the common commercial source (pronase).
3.2. Optimizing the expression of SGAP
Initial attempts to express the SGAP protein in E. coli re-
sulted in very low yields of soluble protein. To improve ex-
pression and solubility of the SGAP gene product, several
methods were tested including the use of various E. coli strains
and expression vectors, and changing the growth temperature
to 18 C. None of these procedures resulted in any signiﬁcant
improvement of expression. Finally, we tested the eﬀect of
sorbitol in the growth media [22]. Indeed, growing the cells
under high osmotic pressure resulted in over 500-fold increase
in cell-associated SGAP activity. Sorbitol is a compatible sol-
ute, which raises the osmotic pressure and presumably induces
production of intracellular osmoprotectants (such as trehalose)
or other stress-response mechanisms that may aﬀect the fold-
ing kinetics of the recombinant protein. Several concentrations
of sorbitol (0.2–1.5 M) in LB and TB media were tested at
several growth temperatures (17–37 C). The best results were
obtained by growing the cells on TB with 1 M sorbitol at 18 C
for 40 h under IPTG induction.
3.3. Puriﬁcation of SGAP
SGAP was puriﬁed from the crude extract by a combination
of heat treatment and anion exchange chromatography. Al-
though S. griseus is not a thermophilic bacterium, the enzyme
is heat stable [17]. The sample was ﬁrst heat-treated for 20 min
in 50 C resulting in recovery of 74% and then was subjected to
anion exchange chromatography on HiPrepTM Q SepharoseTable 1
Puriﬁcation of recombinant SGAP
Step Volume
(ml)
Total protein
(mg)
Total activ
(U)
Crude extracta 250 1.5 103 1.9 105
Heat treatment 185 5 103 1.5 105
Anion exchange 285 180 1.5 105
a The crude extract was obtained from 4-l culture.Fast Flow (Fig. 2). Most of the enzyme activity was eluted as a
single peak at 7 mM NaCl. This puriﬁcation procedure re-
sulted in a total recovery of 74% and a 28-fold puriﬁcation
factor, giving a speciﬁc activity of 830 U/mg protein (Table 1).
This speciﬁc activity is comparable to what was obtained from
the pronase-puriﬁed SGAP (about 500 U/mg protein) [17]. The
overall yield was 50 mg of pure SGAP from 1-l culture. A
recent study by Ni et al. [23] reported the large scale puriﬁ-
cation procedure of a recombinant SGAP, which resulted in a
very low yield of 2.57 mg puriﬁed SGAP from 16-l culture [23].
Thus, the yield obtained in this study is over 300-fold higher.
3.4. Testing catalytic mutants
One of the most direct approaches to evaluate the role of
proposed catalytic residues is to replace them by site directed
mutagenesis and test the properties of the resulting catalytic
mutants [24]. Due to the low activity of the catalytic mutants,
relatively large amounts of the puriﬁed protein are required.
The successful production of the recombinant SGAP in high
yields allowed us to test various catalytic mutants. Based on
the high resolution structure of SGAP, a general catalytic
pathway was proposed (Fig. 1) [12]. These studies suggest that
the conserved Glu131 and Y246 residues are directly involved
in the catalytic mechanism of the enzyme. Glu131 probably
acts as a general base by promoting the nucleophilic attack of
the zinc-bound water on the substrate carbonyl carbon and as
a proton shuttle during the catalytic cycle. This residue may
also be involved in binding the substrate and stabilizing the
tetrahedral transition state. SGAP and AAP share an amino
acid sequence homology of only 30% [19]. Based on their
crystal structures, it appears that they contain a comparable
catalytic core [13] and share a similar double-zinc coordination
[11]. By comparing the SGAP complex structures with reaction
products to the complex of AAP with p-iodo-D-phenylalanine
hydroxamate, it could be seen that they both have a signiﬁcantity Speciﬁc activity
(U/mg)
Yield
(%)
Puriﬁcation factor
(fold)
12 100 1
30 74 2.5
830 74 28
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AAP) with one of the zinc-bound oxygen atoms of the analog
[12,25]. Glu151 was proposed to assist in deprotonation of the
metal bound water as to create the nucleophile hydroxide of
the initial catalytic reaction of AAP [14].
To test the role of Glu131 in SGAP, it was replaced by site
directed mutagenesis to either Gln, Asp or Ala. Gln is a non-
ionizable amino acid with a terminal amide group, allowing it
to form hydrogen bonds, but it cannot act as a general base.
Asp is shorter by one carbon from Glu, thus this replacement
should aﬀect the eﬃciency of deprotonating the zinc-bound
water molecule. The Glu131Ala replacement resulted in over
ﬁve orders of magnitude decrease in kcat as compared to the
wild type, but did not signiﬁcantly aﬀect Km (Table 2). This
very large reduction in activity is consistent with Glu131 being
the general base residue. The two other replacements,
Glu131Gln and Glu131Asp, also resulted in a large reduction
in kcat of about four orders of magnitude, reﬂecting the fact
that these residues may function to some extent as proton
donors. Similar level of reduction in activity was obtained with
other general base catalytic mutants of metallopeptidases, in-
cluding the monozinc APA [26–28], peptide deformylase [29],
neutral endopeptidase (EC 3.4.24.11) [30], human matrilysin
[31], leukotriene A4 hydrolase [32], glutamate carboxypepti-
dase II [33] and thermolysin [24,34].
The proposed role of Y246 in SGAP is to polarize the car-
bonyl group of the N-terminal substrate and to make it more
accessible to a nucleophilic attack by the activated water
molecule. In addition, this residue may also stabilize the tet-
rahedral intermediate. Tyr246 was replaced to either Ser, Ala
or Phe, and all the replacements resulted in about two orders
of magnitude decrease in activity (Table 2). The 100-fold de-
crease of the kcat value suggests that the phenolic hydroxyl of
Tyr246 plays an important role in substrate hydrolysis. Studies
with monozinc metalloproteinases, in which a similar func-
tional residue was replaced, also resulted in a 100-fold reduc-
tion in kcat [27,31,35]. The reduction in activity of the Tyr246
replacements is again consistent with the role of this residue in
polarizing the carbonyl group of the peptide bond and stabi-
lizing the transition state by hydrogen bond interaction with
one of the tetrahedral intermediate oxygen atoms.
Aligning SGAP to other family M28 peptidases reveals that
the Tyr246 is almost fully conserved and located near a con-
served His residue that is suggested to act as a Zn ligand [12].
PSMA appeared to contain an active site resembling that of
SGAP. Replacement of the equivalent Tyr552 to Phe in PSMA
reduced Vmax 10-fold [33]. Tyr was also proved to play a criticalTable 2
Kinetic parameters for hydrolysis of leu-pNAby SGAP and its catalytic
mutants
Enzyme kcat (s1)a Km (mM)a kcat/Km (s1 mM1)
WT 3.9 102 0.57 689
E131A 3.3 103 0.33 0.01
E131D 4 102 0.4 0.1
E131Q 6 102 0.39 0.16
Y246A 2.2 0.78 2.8
Y246F 5.6 0.33 17.1
Y246S 8 0.7 11.6
a The reaction was performed at 30 C in a continuous assay. Reaction
solution contained 50 mM MOPS, pH 8, 3 lM ZnCl2 and the ap-
propriate enzyme and substrate concentrations.role in the catalytic reaction and in substrate binding of bovine
carboxypeptidase A. Replacing this residue to Ala or Phe re-
sulted in 10-fold decrease of kcat and 4–11-fold increase in Km
[36]. These ﬁndings indicate again that this residue participates
in catalysis. Other APs contain alternative amino acid residues
in their active site, such as His, that are involved in transition
state binding [35]. Mutation in the His residue resulted in 100-
fold reduction of kcat similar to what was obtained with the
SGAP Tyr246 mutants in this study.
In conclusion, the successful production of active soluble
recombinant SGAP allowed us for the ﬁrst time to test the role
of the structure based catalytic residues of double-zinc AP. The
kinetic results provide further evidence that Glu131 acts as a
general base and that Tyr246 is probably involved in stabil-
ization of the tetrahedral intermediate. The recombinant pro-
teins could also be crystallized. Preliminary results suggest that
the SGAP E131D mutant crystallizes in the monoclinic space
group P21.
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